Opium and heroin alter biochemical parameters of human's serum

American Journal of Drug and Alcohol Abuse

Volumn 36, Issue 3, 2010, Pages 135-139

  Kouros, Divsalar ^a   Tahereh, Haghpanah ^a   Mohammadreza, Afarinesh ^a   Minoo, Mahmoudi Zarandi ^b  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Addiction; Biochemical parameters; Heroin; Iran; Opium; Serum

Indexed keywords

CALCIUM ION; CHOLESTEROL; CREATININE; DIAMORPHINE; GLUCOSE; OPIATE; POTASSIUM ION; PROTEIN; SODIUM ION; TRIACYLGLYCEROL; UREA; URIC ACID;

ADULT; ARTICLE; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CHROMATOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEROIN DEPENDENCE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PROTEIN BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; VOLUNTEER;

ADULT; BLOOD GLUCOSE; CALCIUM; CASE-CONTROL STUDIES; CHOLESTEROL; CROSS-SECTIONAL STUDIES; HEROIN; HUMANS; IRAN; MALE; OPIOID-RELATED DISORDERS; OPIUM; POTASSIUM; URIC ACID;

EID: 77952417634     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952991003734277     Document Type: Article

References (45)

1. Sertürner F. W. A. F. Darstellung der reinen Mohnsäure (Opiumsäure) nebst einer chemischen Untersuchung des Opiums mit vorzüglicher Hinsicht auf einen darin neu entdeckten Stoff und die dahin gehörigen Bemerckungen. J. Pharm. Ä rzte Apotheker Chem 1806;14:47-93.
2. Costa AM. World Drug Report 2007. In: United Nations Office on Drugs and Crime. 2007; pp. 37-61.
3. Aksenov VS, Numanov IU, Pogosov AV, Degtyarev VA. Chromatographic investigation of the alkaloids of the opium poppy and their acetyl derivatives. Chemistry of Natural Compounds 1993;29:92-94.
4. Mahani SE, Motamedi F, Ahmadiani A. Involvement of hypothalamic pituitary adrenal axis on the nifedipine-induced antinociception and tolerance in rats. Pharmacol Biochem Behav 2006;85:422-427.
5. Ipp E, Schusdziarra V, Harris V, Unger RH. Morphine-induced hyperglycemia: role of insulin and glucagon. Endocrinology 1980;107:461-463.
6. Ipp E, Dobbs R, Unger RH. Morphine and beta-endorphin influence the secretion of the endocrine pancreas. Nature 1978;276:190-191. (Pubitemid 9068253)
7. Molina PE, Hashiguchi Y, Ajmal M, Mazza M, Abumrad NN. Differential homodynamic, metabolic and hormonal effects of morphine and morphine-6- glucoronide. Brain Research 1994;664:126-132.
8. Bossone CA, Hannon JP. Metabolic actions of morphine in conscious chronically instrumented pigs. Am J Physiol 1991;260: R1051-1057.
9. Gupta K, Weber ML. Renal effects of opioid exposure: Considerations for therapeutic use. J Opioid Manag 2006;2:236-240.
10. Kapusta DR, Dzialowski EM. Central mu opioids mediate differential control of urine flow rate and urinary sodium excretion in conscious rats. Life Sci 1995;56: PL243-248.
11. Mercadante S, Arcuri E. Opioids and renal function. J Pain 2004;5:2-19.
12. Venturella VS. Natural Product. In: Gennard AR (ed.). The Science and Practice of Pharmacy. 19th ed. Remington: Mack Publishing Company, 1995.
13. Buchbauer G, Nikiforov A, Remberg B. Headspace constituents of opium. Planta Med 1994;60:181-183.
14. Karam GA, Rashidinejad HR, Aghaee MM, AhmadiJ, Rahmani MR, Mahmoodi M, Azin H, Mirzaee MR, Khaksari M. Opium can differently alter blood glucose, sodium and potassium in male and female rats. Pak J Pharm Sci 2008;21:180-184.
15. Feldberg W, Gupta KP. Morphine hyperglycaemia. J Physiol 1974;238:487-502.
16. Radosevich PM, Williams PE, Lacy DB, McRae JR, Steiner KE, Cherrington AD, Lacy WW, Abumrad NN. Effects of morphine on glucose homeostasis in the conscious dog. J Clin Invest 1984;74:1473-1480.
17. Brase DA, Singha AK, Estrada U, Lux F, Dewey WL. Hypoglycemia induced by intrathecal opioids in mice: Stereospecificity, drug specificity and effect of fasting. J Pharmacol Exp Ther 1990;253:899-904.
18. Brase DA, Ward CR, Tripathi HL, Dewey WL. An insulin-independent mechanism of intrathecal morphine-induced hypoglycemia in mice: Mediation through a central alpha-2 adrenergic pathway. J Pharmacol Exp Ther 1991;257:587-594.
19. Azod L, Rashidi M, Afkhami-Ardekani M, Kiani G, Khoshkam F. Effect of opium addiction on diabetes. Am J Drug Alcohol Abuse 2008;34:383-388.
20. Karam GA, Reisi M, Kaseb AA, Khaksari M, Mohammadi A, Mahmoodi M. Effects of opium addiction on some serum factors in addicts with noninsulin-dependent diabetes mellitus. Addict Biol 2004;9:53-58.
21. Liu IM, Cheng JT. Mediation of Endogenous {beta}-Endorphin in the Plasma Glucose-lowering Action of Herbal Products Observed in Type 1-Like Diabetic Rats. Evid Based Complement Alternat Med 2008;1-9.
22. Molina PE, Hashiguchi Y, Ajmal M, Mazza M, Abumrad NN. Differential hemodynamic, metabolic and hormonal effects of morphine and morphine-6- glucuronide. Brain Res 1994;664:126-132.
23. Terner JM, Lomas LM, Smith ES, Barrett AC, Picker MJ. Pharmacogenetic analysis of sex differences in opioid antinociception in rats. Pain 2003;106:381-391.
24. Strother A, Chau LS. Influence of glucose (in vivo or in vitro) on duration of narcotic analgesics and on the kinetics of drug metabolism. Pharmacology 1980;21:161-166.
25. Strother A, Throckmorton JK, Herzer C. The influence of high sugar consumption by mice on the duration of action of barbiturates and in vitro metabolism of barbiturates, aniline and p-nitroanisole. J Pharmacol Exp Ther 1971;179:490-498.
26. Gosnell BA, Grace M, Billington CJ, Levine AS. Effects of streptozotocininduced diabetes on feeding stimulated by centrally administered opioid agonists. Life Sci 1989;45:31-40.
27. Thomas J, Jones G, Scarinci I, Brantley P. A descriptive and comparative study of the prevalence of depressive and anxiety disorders in low-income adults with type 2 diabetes and other chronic illnesses. Diabetes Care 2003;26:2311-2317.
28. Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 1997;20:585-590.
29. Kojima K, Mohamed S, Fujimaru Y, Mori Y, Kaname H, Sumida Y, Kinukawa N, Tashiro N. Effects of both the emotional behavior and feeding conditions on the circulating plasma volume and plasma glucose levels in cats. Auton Neurosci 2000;86:58-64.
30. Laso FJ, Madruga I, Borras R, Bajo A, Gonzalez-Buitrago JM, de Castro S. Hypokalemia in opiate overdose. Clin Investig 1994;72:471.
31. Laso FJ, Gonzalez-Buitrago JM, Martin-Ruiz C, Vicens E, Moyano JC. Inter-relationship between serum potassium and plasma catecholamines and 3':5' cyclic monophosphate in alcohol withdrawal. Drug Alcohol Depend 1990;26:183-188.
32. Elnimr T, Hashem A, Assar R. Heroin dependence effects on some major and trace elements. Biol Trace Elem Res 1996;54:153-162.
33. Kim TW, Alford DP, Malabanan A, Holick MF, Samet JH. Low bone density in patients receiving methadone maintenance treatment. Drug Alcohol Depend 2006;85:258-262.
34. Pedrazzoni M, Vescovi PP, Maninetti L, Michelini M, Zaniboni G, Pioli G, Costi D, Alfano FS, Passeri M. Effects of chronic heroin abuse on bone and mineral metabolism. Acta Endocrinol (Copenh) 1993;129:42-45.
35. Daniell HW. Opioid osteoporosis. Arch Intern Med 2004;164:338.
36. Hejazian S, Dashti M, Rafati A. The effect of opium on serum LH, FSH and testosterone concentration in addicted men. Iranian Journal of Reproductive Medicine 2007;1:35-38.
37. Katz N, Mazer NA. The impact of opioids on the endocrine system. Clin J Pain 2009;25:170-175.
38. Fraser LA, Morrison D, Morley-Forster P, Paul TL, Tokmakejian S, Larry Nicholson R, Bureau Y, Friedman TC, Van Uum SH. Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women. Exp Clin Endocrinol Diabetes 2009;117:38-43.
39. Tagliaro F, Capra F, Dorizzi R, Luisetto G, Accordini A, Renda E, Parolin A. High serum calcitonin levels in heroin addicts. J Endocrinol Invest 1984;7:331-333.
40. Sumathi T, Niranjali Devaraj S. Effect of Bacopa monniera on liver and kidney toxicity inchronic use of opioids. Phytomedicine 2009;16:897-903.
41. Divsalar K, Meymandi MS, Saravani R, Zarandi MM, Shaikh-Al-Eslami A. Electrophoretic profile of serum proteins in opium and heroin dependents. Am J Drug Alcohol Abuse 2008;34:769-773.
42. Sapira JD, Jasinski DR, Gorodetzky CW. Liver disease in narcotic addicts. II. The role of the needle. Clin Pharmacol Ther 1968;9:725-739.
43. Ho WK, Wen HL, Fung KP, Ng YH, Au KK, Ma L. Comparison of plasma hormonal levels between heroin-addicted and normal subjects. Clin Chim Acta 1977;75:415-419.
44. Wilczek H, Ceska R, Zlatohlavek L. Serum lipids in drug addicts. Vnitr Lek 2004;50:584-586.
45. Cherubin CE. The medical sequelae of narcotic addiction. Ann Intern Med 1967;67:23-33.